We are live on ! Find out more
OBCI

Ocean Bio-Chem Inc

Delisted

OBCI was delisted on the 8th of August, 2022.

16 hedge funds and large institutions have $1.22M invested in Ocean Bio-Chem Inc in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

14% more funds holding

Funds holding: 1416 (+2)

11% more capital invested

Capital invested by funds: $1.1M → $1.22M (+$122K)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

OBCI Hedge Fund Activity: Q1 2019 in Review

16 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem Inc (OBCI) for Q1 2019, worth a combined $1.22M — up 11% from $1.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new OBCI positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $54.2K. The largest seller was Shepherd Kaplan Krochuk, exiting entirely with an estimated $114K sold.

  • 16 institutional investors held Ocean Bio-Chem Inc (OBCI) as of Q1 2019, up from 14 in Q4 2018.
  • Funds reported $1.22M of Ocean Bio-Chem Inc stock for Q1 2019, up 11% quarter-over-quarter.
  • 3 funds opened new Ocean Bio-Chem Inc positions in Q1 2019 and 1 closed out, a net change of +2 holders.
  • The largest Ocean Bio-Chem Inc buyer in Q1 2019 was Citadel Advisors, an estimated $54.2K added.
  • The largest Ocean Bio-Chem Inc seller in Q1 2019 was Shepherd Kaplan Krochuk, an estimated $114K sold.

Based on aggregated 13F filings for Q1 2019.